Aptevo Therapeutics Financial Overview
Aptevo Therapeutics's market cap is currently $18.03M. The company's EPS TTM is $-2.23; its P/E ratio is >-0.01; Aptevo Therapeutics is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-0.45. See an overview of income statement, balance sheet, and cash flow financials.
